We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKT icon
1626
Rocket Companies
RKT
$39.6B
$2.3M 0.01%
+328,042
New +$2.4M
SWX icon
1627
Southwest Gas
SWX
$6.7B
$2.3M 0.01%
37,088
-24
-0.1% -$1.63K
ADP icon
1628
CALL
Automatic Data Processing
ADP
$106B
$2.29M 0.01%
9,600
+700
+8% +$172K
WVE icon
1629
Wave Life Sciences
WVE
$1.13B
$2.29M 0.01%
+327,450
New +$1.51M
ILPT
1630
Industrial Logistics Properties Trust
ILPT
$603M
$2.29M 0.01%
699,747
-307,771
-31% -$1.28M
WQGA.WS
1631
CALL
DELISTED
World Quantum Growth Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WQGA.WS
$2.29M 0.01%
222,881
PEPLW
1632
CALL
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$2.28M 0.01%
223,272
XLU icon
1633
CALL
State Street Utilities Select Sector SPDR ETF
XLU
$23.4B
$2.28M 0.01%
+64,600
New +$2.2M
POSH
1634
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$2.27M 0.01%
127,208
+81,062
+176% +$1.44M
FISV
1635
CALL
Fiserv Inc
FISV
$28.9B
$2.27M 0.01%
+22,500
New +$2.24M
EACPW
1636
CALL
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$2.27M 0.01%
224,994
IBER.WS
1637
CALL
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$2.27M 0.01%
224,997
SP
1638
DELISTED
SP Plus Corporation
SP
$2.26M 0.01%
65,198
+12,813
+24% +$442K
FMIVW
1639
CALL
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
$2.26M 0.01%
224,995
AMN icon
1640
AMN Healthcare
AMN
$1.35B
$2.26M 0.01%
21,969
-64,172
-74% -$7.39M
IYZ icon
1641
iShares US Telecommunications ETF
IYZ
$1.19B
$2.25M 0.01%
+100,400
New +$2.24M
LBTYA icon
1642
Liberty Global Class A
LBTYA
$3.49B
$2.25M 0.01%
+118,950
New +$2.16M
WRK
1643
DELISTED
WestRock Company
WRK
$2.25M 0.01%
63,994
-261,070
-80% -$9.1M
GD icon
1644
General Dynamics
GD
$106B
$2.25M 0.01%
+9,058
New +$2.21M
ARNC
1645
DELISTED
Arconic Corporation
ARNC
$2.25M 0.01%
106,205
-333,257
-76% -$6.97M
GM icon
1646
CALL
General Motors
GM
$81.7B
$2.25M 0.01%
66,800
+66,300
+13,260% +$2.45M
ALDX icon
1647
Aldeyra Therapeutics
ALDX
$95.3M
$2.25M 0.01%
322,581
+122,418
+61% +$700K
MSDAW
1648
CALL
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$2.24M 0.01%
221,591
TASK icon
1649
TaskUs
TASK
$568M
$2.22M 0.01%
131,569
-438,174
-77% -$8.23M
IR icon
1650
Ingersoll Rand
IR
$33.9B
$2.22M 0.01%
+42,545
New +$2.17M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.